This year's Viewpoint Medtech took place on 18 November 2024 at the premises of ERBE Elektromedizin GmbH in Rangendingen. This series of events is an interactive forum th...
CeGaT, a global provider of genetic diagnostics and sequencing services, announces significant advancements in exome diagnostics with the latest update to its ExomeXtra® enrichment. The new update is ...
TÜBINGEN, Germany/BOSTON, USA – 12. November 2024CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medi...
On 5 and 6 November 2024, the NWE Annual Event took place in Dublin, where we enjoyed an inspiring and productive day of workshops, presentations and networking opportuni...
CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”...
Cyber Valley is bringing together AI expertise to drive innovation in the healthcare sector.The Cyber Valley Health Cluster strengthens collaboration between research, start-ups, and industry in the f...
This year's on-site visits to the Science2Start prizewinners once again provided exciting insights into the winners' current projects. This personal exchange helps to lea...
A quantum sensor that can register nerve impulses without contact opens up new possibilities in prosthetics. Researchers at Fraunhofer IPA are developing together with th...
In addition to a small refresh of the design, we have above all reorganised the structure of our website. The updated menu and new elements ensure an optimised user exper...
On 14 October 2024, BioRegio STERN Management GmbH welcomed a delegation from the US state of Montana to Stuttgart. This interesting exchange was organised at the request of AHP International GmbH &am...
Houston, Texas and Tuebingen, Germany, October 10, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in ...
Houston, Texas and Tuebingen, Germany, October 10, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirec...
He was instrumental in shaping the University of Hohenheim and setting it on the road to success. Prof. Dr. Stephan Dabbert was voted the most popular university presiden...
The Healthtech Innovation Days (HTID #6), a central European event for healthcare innovation, took place in Paris on 17 and 18 September. Around 400 participants, includi...
Houston, Texas and Tuebingen, Germany, September 16, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active i...
Phase 2 data demonstrated positive immune responses to A and B strains, with acceptable safety and reactogenicity profile, meeting all pre-defined study endpoints
Vaccin...
BIOPRO Baden-Württemberg publishes first results of a new WifOR study
The industrial healthcare sector (iGW) plays a central role in the economy in Baden-Württemberg. In ...
A team of scientists from HHMI’s Janelia Research Campus and the University of Tübingen have found a way to build artificial neural networks which accurately predict comp...
CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”...
CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”...
